Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.

Racey Muchilwa, Head of Sub-Saharan Africa for Novartis, reflects on her mother’s calling as a teacher.

Chief Talent and People Solutions Officer Tripti Jha’s mother prioritized her learning in a rural region of India with limited opportunities for girls.

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.

Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.

Improved versions of our new digital platform for heart failure disease management in China have been developed since April, 2020 rollout.

Novartis researchers aim to preserve kidney function – and quality of life – for patients.

Novartis researchers are using data to accelerate drug development.

These stories offer a glimpse into the lives of people touched by a new era of medicine.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.